Agile Therapeutics
AGRX
$0.40
Share price
0.00%
Change (1 day)
-93.94%
Change (1 year)
Categories
Operating Margin for Agile Therapeutics (AGRX)
Operating Margin as of April 2024 (TTM): -451.32%
According to Agile Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -451.32%. At the end of 2021 the company had an Operating Margin of -1,826.24%.
Operating Margin history for Agile Therapeutics from 2021 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -1,826.24% | -73.62% |
| 2020 | -6,922.96% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -105.07% | 🇺🇸 USA |
 Pfizer PFE | 34.61% | -107.67% | 🇺🇸 USA |
 Merck MRK | 27.73% | -106.14% | 🇺🇸 USA |
 TherapeuticsMD TXMD | 1.53% | -100.34% | 🇺🇸 USA |
 Antares Pharma ATRS | 31.38% | -106.95% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.